Samsara BioCapital, 10% Owner: Mineralys Therapeutics MLYS Buy · Filed 23/02/16

Trade details

Type: Insider buy
Amount: $15,000,000
Shares · price: 937,500 sh · $16.00 a share
Held after: 4,519,361 sh
Stock: Mineralys Therapeutics MLYS
Person: Samsara BioCapital10% Owner
Trade date: 23/02/14
Filed: 23/02/16
Days to filing: 2 days

11 insiders bought this week

Insiders buying this week: 11 insiders
Holding change: +26.2%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/15~23/03/16

Samsara BioCapital's recent trades

Samsara BioCapital10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$1.2M
244,300 sh
$1.2M
Filed 05/22
Traded 05/20
Samsara BioCapital10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$5M
479,847 sh
$5M
Filed 02/17
Traded 25/12/18
Samsara BioCapital10% Owner
BuyMineralys Therapeutics
Buy
Mineralys Therapeutics
MLYS
$8.1M
600,000 sh
$8.1M
Filed 25/03/17
Traded 25/03/13
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$516.8K
20,748 sh
$516.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$406.8K
15,219 sh
$406.8K
Filed 24/11/27
Traded 24/11/26